Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.1B | 6.1B | 5.7B | 6.2B |
Cost of revenue | 3.9B | 3.6B | 3.4B | 3.5B |
Gross profit | 3.2B | 2.4B | 2.3B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.2B | 1.3B | 1.1B | 1.1B |
Operating income | 2.0B | 1.1B | 1.1B | 1.6B |
Non operating interest income | ||||
Income | 19M | 22M | 12M | 12M |
Expense | 245M | 231M | 154M | 156M |
Other income expense | 48M | 76M | 69M | 67M |
Pretax income | 1.8B | 1.0B | 1.0B | 1.6B |
Tax provision | 415M | 208M | 283M | 425M |
Net income | 1.4B | 801M | 752M | 1.1B |
Basic EPS | 2.8 | 1.6 | 1.5 | 2.3 |
Diluted EPS | 2.8 | 1.6 | 1.5 | 2.3 |
Basic average shares | 492M | 491M | 492M | 492M |
Diluted average shares | 495M | 496M | 496M | 496M |
EBITDA | 2.3B | 1.4B | 1.4B | 1.9B |
Net income from continuing op. | 1.4B | 801M | 752M | 1.1B |
Minority interests | -31M | -13M | -5M | -15M |
Preferred stock dividends | — | — | — | — |